Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.

Najlaoui F, Pigeon P, Aroui S, Pezet M, Sancey L, Marrakchi N, Rhouma A, Jaouen G, De Waard M, Busser B, Gibaud S.

J Pharm Pharmacol. 2018 Nov;70(11):1474-1484. doi: 10.1111/jphp.12998. Epub 2018 Aug 23.

PMID:
30141195
2.

A Decision Support Tool Facilitating Medicine Design for Optimal Acceptability in The Older Population.

Vallet T, Belissa E, Laribe-Caget S, Chevallier A, Chedhomme FX, Leglise P, Piccoli M, Michelon H, Bloch V, Meaume S, Grancher AS, Bachalat N, Boulaich I, Abdallah F, Rabus M, Rwabihama JP, Ribemont AC, Lachuer C, Perquy I, Lechowski L, Delahaye A, Depoisson M, Orven Y, Guinot C, Gibaud S, Michel C, Mahiou A, Belbachir SA, Trouvin JH, Dufaÿ-Wojcicki A, Boudy V, Ruiz F.

Pharm Res. 2018 May 7;35(7):136. doi: 10.1007/s11095-018-2424-3.

3.

The effect of intravenous isosorbide dinitrate in acute decompensated heart failure in hospital.

Chambord J, Attivi D, Thuus V, Zeghmouli C, Gibaud S.

Int J Clin Pharm. 2017 Jun;39(3):536-541. doi: 10.1007/s11096-017-0459-x. Epub 2017 Apr 3.

PMID:
28374342
4.

Prevalence of Mycoplasma genitalium Infection and Relationship with Symptoms Among Adults Attending a Sexual Health Centre.

Lefebvre M, Coutherut J, Gibaud S, Biron C, Chalopin M, Bernier C, Raffi F.

Acta Derm Venereol. 2017 Apr 6;97(4):543-545. doi: 10.2340/00015555-2585. No abstract available.

5.

Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer.

Shah SU, Socha M, Sejil C, Gibaud S.

Ann Pharm Fr. 2017 Mar;75(2):95-104. doi: 10.1016/j.pharma.2016.09.001. Epub 2016 Oct 19.

PMID:
27770996
6.

Thiomers and their potential applications in drug delivery.

Shah KU, Shah SU, Dilawar N, Khan GM, Gibaud S.

Expert Opin Drug Deliv. 2017 May;14(5):601-610. doi: 10.1080/17425247.2016.1227787. Epub 2016 Sep 6. Review.

PMID:
27548003
7.

Synthesis of S-nitrosoglutathione-alginate for prolonged delivery of nitric oxide in intestines.

Shah SU, Socha M, Fries I, Gibaud S.

Drug Deliv. 2016 Oct;23(8):2927-2935. Epub 2015 Dec 15.

PMID:
26666370
8.

Phthalimido-ferrocidiphenol cyclodextrin complexes: Characterization and anticancer activity.

Najlaoui F, Pigeon P, Abdelkafi Z, Leclerc S, Durand P, Ayeb ME, Marrakchi N, Rhouma A, Jaouen G, Gibaud S.

Int J Pharm. 2015 Aug 1;491(1-2):323-34. doi: 10.1016/j.ijpharm.2015.06.043. Epub 2015 Jun 29.

PMID:
26136201
9.

Synthesis and characterization of S-nitrosoglutathione-oligosaccharide-chitosan as a nitric oxide donor.

Shah SU, Martinho N, Socha M, Pinto Reis C, Gibaud S.

Expert Opin Drug Deliv. 2015 Aug;12(8):1209-23. doi: 10.1517/17425247.2015.1028916. Epub 2015 Mar 24.

PMID:
25804290
10.

First experience of a multicenter external quality assessment of molecular 16S rRNA gene detection in bone and joint infections.

Plouzeau C, Bémer P, Valentin AS, Héry-Arnaud G, Tandé D, Jolivet-Gougeon A, Vincent P, Kempf M, Lemarié C, Guinard J, Bret L, Cognée AS, Gibaud S, Burucoa C, Corvec S; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

J Clin Microbiol. 2015 Feb;53(2):419-24. doi: 10.1128/JCM.02413-14. Epub 2014 Nov 19.

11.

Effect of intravenous hydration in patients receiving bisphosphonate therapy.

Attivi D, Kosmalski G, Zeghmouli C, Gibaud S.

Int J Clin Pharm. 2014 Dec;36(6):1277-81. doi: 10.1007/s11096-014-9994-x. Epub 2014 Sep 10.

12.

Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicenter cross-sectional study.

Bémer P, Plouzeau C, Tande D, Léger J, Giraudeau B, Valentin AS, Jolivet-Gougeon A, Vincent P, Corvec S, Gibaud S, Juvin ME, Héry-Arnaud G, Lemarié C, Kempf M, Bret L, Quentin R, Coffre C, de Pinieux G, Bernard L, Burucoa C; Centre de Référence des Infections Ostéo-articulaires du Grand Ouest (CRIOGO) Study Team.

J Clin Microbiol. 2014 Oct;52(10):3583-9. doi: 10.1128/JCM.01459-14. Epub 2014 Jul 23.

13.

Continuous infusion of piperacillin/tazobactam in patients with severe infections: A possible pharmacokinetic optimisation?

Attivi D, Gibaud S.

Ann Pharm Fr. 2014 May;72(3):146-51. doi: 10.1016/j.pharma.2013.12.006. Epub 2014 Jan 20. Review.

PMID:
24780830
14.

The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma.

Becherirat S, Lanhers MC, Socha M, Yemloul M, Astier A, Loboda C, Aniceto N, Gibaud S.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):560-8. doi: 10.1016/j.ejpb.2013.06.021. Epub 2013 Jul 4.

PMID:
23831266
15.

Characterization of mitotane (o,p'-DDD)--cyclodextrin inclusion complexes: phase-solubility method and NMR.

Alfonsi R, Attivi D, Astier A, Socha M, Morice S, Gibaud S.

Ann Pharm Fr. 2013 May;71(3):186-92. doi: 10.1016/j.pharma.2013.02.001. Epub 2013 Mar 15.

PMID:
23622697
16.

Microemulsions for oral administration and their therapeutic applications.

Gibaud S, Attivi D.

Expert Opin Drug Deliv. 2012 Aug;9(8):937-51. doi: 10.1517/17425247.2012.694865. Epub 2012 Jun 5. Review.

17.

Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis.

Njamkepo E, Bonacorsi S, Debruyne M, Gibaud SA, Guillot S, Guiso N.

J Clin Microbiol. 2011 Dec;49(12):4347-8. doi: 10.1128/JCM.01272-11. Epub 2011 Oct 19.

18.

Melarsoprol cyclodextrin inclusion complexes as promising oral candidates for the treatment of human African trypanosomiasis.

Rodgers J, Jones A, Gibaud S, Bradley B, McCabe C, Barrett MP, Gettinby G, Kennedy PG.

PLoS Negl Trop Dis. 2011 Sep;5(9):e1308. doi: 10.1371/journal.pntd.0001308. Epub 2011 Sep 6.

19.

Speciation of arsenic in urine following intravenous administration of arsthinol in mice.

Ajana I, Astier A, Gibaud S.

Eur J Drug Metab Pharmacokinet. 2010 Sep;35(1-2):59-65.

PMID:
21495268
20.

Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.

Ajana I, Astier A, Gibaud S.

J Pharm Pharmacol. 2009 Oct;61(10):1295-301. doi: 10.1211/jpp/61.10.0004.

21.

Development of microemulsion of mitotane for improvement of oral bioavailability.

Attivi D, Ajana I, Astier A, Demoré B, Gibaud S.

Drug Dev Ind Pharm. 2010 Apr;36(4):421-7. doi: 10.3109/03639040903225083.

PMID:
19778161
22.

Comparison of nanosuspensions and hydroxypropyl-beta-cyclodextrin complex of melarsoprol: pharmacokinetics and tissue distribution in mice.

Ben Zirar S, Astier A, Muchow M, Gibaud S.

Eur J Pharm Biopharm. 2008 Oct;70(2):649-56. doi: 10.1016/j.ejpb.2008.05.012. Epub 2008 Jun 6.

PMID:
18582565
24.

Cyclodextrin inclusion complexes of the central analgesic drug nefopam.

Brun H, Paul M, Razzouq N, Binhas M, Gibaud S, Astier A.

Drug Dev Ind Pharm. 2006 Nov-Dec;32(10):1123-34.

25.

Melarsoprol-cyclodextrins inclusion complexes.

Gibaud S, Zirar SB, Mutzenhardt P, Fries I, Astier A.

Int J Pharm. 2005 Dec 8;306(1-2):107-21. Epub 2005 Oct 25.

26.

Poly(epsilon-caprolactone) and Eudragit microparticles containing fludrocortisone acetate.

Gibaud S, Jabir Al Awwadi N, Ducki C, Astier A.

Int J Pharm. 2004 Jan 28;269(2):491-508.

PMID:
14706260
27.

Slow-release melarsoprol microparticles.

Gibaud S, Gaia A, Astier A.

Int J Pharm. 2002 Aug 28;243(1-2):161-6.

PMID:
12176304
28.

Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods.

Gibaud S, Bonneville A, Astier A.

Int J Pharm. 2002 Aug 21;242(1-2):197-201.

PMID:
12176246
29.

[Targeting bone marrow with the help of polyalkylcyanoacrylate nanoparticles].

Gibaud S, Weingarten C, Andreux JP, Couvreur P.

Ann Pharm Fr. 1999 Jul;57(4):324-31. French.

PMID:
10472705
30.

Polyalkylcyanoacrylate nanoparticles as carriers for granulocyte-colony stimulating factor (G-CSF).

Gibaud S, Rousseau C, Weingarten C, Favier R, Douay L, Andreux JP, Couvreur P.

J Control Release. 1998 Mar 2;52(1-2):131-9.

PMID:
9685943
31.

Splenic trapping of nanoparticles: complementary approaches for in situ studies.

Demoy M, Gibaud S, Andreux JP, Weingarten C, Gouritin B, Couvreur P.

Pharm Res. 1997 Apr;14(4):463-8.

PMID:
9144732
32.

Cells involved in the capture of nanoparticles in hematopoietic organs.

Gibaud S, Demoy M, Andreux JP, Weingarten C, Gouritin B, Couvreur P.

J Pharm Sci. 1996 Sep;85(9):944-50.

PMID:
8877884
33.

Increased bone marrow toxicity of doxorubicin bound to nanoparticles.

Gibaud S, Andreux JP, Weingarten C, Renard M, Couvreur P.

Eur J Cancer. 1994;30A(6):820-6.

PMID:
7917543

Supplemental Content

Loading ...
Support Center